项目                                                 2019年1-6月    2018年度    2017年度    2016年度

营业收入（万元）                                     45434.84       70045.29    34750.26    27801.94

净利润（万元）                                       3545.39        6243.64     3717.75     2123.88

核心技术产品收入（万元）                             34483.52       49886.97    24012.91    17139.24

核心技术产品收入占比（%）                            75.9           71.22       69.1        61.65

研发投入（万元）                                     3012.9         4525.77     2206.79     1648.36

新药研发投入（万元）                                 965.68         1729        939.53      1247.14

新药研发投入占研发投入比重（%）                      32.05          38.2        42.57       75.66

剔除一次性评价投入后的研发投入（万元）               1644.51        2622.62     1466.73     1648.36

新药研发投入占剔除一次性评价后                       58.72          65.93       64.06       75.66

研发投入比重（%）                                                                               

　　数据来源/公司招股说明书及问询函回复